← back to search

Shengping Yu

Nantong University · CN
Area of research
Genetics · Cancer Research
Research interest
Research focused on Cancer research and Glioma, with related work in Glioblastoma, RHOA, Phosphorylation. Notable publications include 'ACT001 reduces the expression of PD-L1 by inhibiting the phosphorylation of STAT3 in glioblastoma', 'Notch1 is a prognostic factor that is distinctly activated in the classical and proneural subtype of glioblastoma and that promotes glioma cell survival via the NF-κB(p65) pathway', and 'NKCC1 promotes EMT‐like process in GBM via RhoA and Rac1 signaling pathways'.
h-index
—
citations
154
works
1
NIH funding
—
primary concept
—
email
✉ Find email ↗

Recent publications

ACT001 reduces the expression of PD-L1 by inhibiting the phosphorylation of STAT3 in glioblastoma
Theranostics 2020cited by 154position: middledoi
Notch1 is a prognostic factor that is distinctly activated in the classical and proneural subtype of glioblastoma and that promotes glioma cell survival via the NF-κB(p65) pathway
Cell Death and Disease 2018cited by 89position: middledoi
NKCC1 promotes EMT‐like process in GBM via RhoA and Rac1 signaling pathways
Journal of Cellular Physiology 2018cited by 47position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Xuejun Yang · Ministry of Education of the People's Republic of China3 papers (2018–2020)Haiwen Ma · Ministry of Education of the People's Republic of China2 papers (2018–2020)Luqing Tong · Ministry of Education of the People's Republic of China2 papers (2018–2020)— · 2 papers (2018–2018)Jiabo Li · Robert H. Lurie Comprehensive Cancer Center of Northwestern University2 papers (2018–2020)Yi Li · Peking University2 papers (2018–2020)Yu Lin · National Taipei University of Technology2 papers (2018–2020)Peidong Liu · Guangzhou University of Chinese Medicine2 papers (2018–2020)Yang Xie · Hebei General Hospital2 papers (2018–2020)Bo Liu · Beijing YouAn Hospital1 papers (2018–2018)Qiuying Li · Shenyang Pharmaceutical University1 papers (2020–2020)Xun Jin · Chinese Academy of Medical Sciences & Peking Union Medical College1 papers (2020–2020)Qiang Huang · South China Agricultural University1 papers (2020–2020)Michael Lim · Stanford University1 papers (2020–2020)Feng Yuan · Anhui Medical University1 papers (2018–2018)Tianna Zhao · Johns Hopkins Medicine1 papers (2020–2020)Ravi Medikonda · Johns Hopkins Medicine1 papers (2020–2020)Zhennan Tao · Ministry of Education of the People's Republic of China1 papers (2018–2018)Meng Zhu · Harvard University1 papers (2018–2018)John Choi · Stanford University1 papers (2020–2020)